Chemoinformaics analysis of Benzene, 4-ethenyl-1,2-dimethyl-
| Molecular Weight | 132.206 | nRot | 1 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 7 |
| Exact Molecular Weight | 132.094 | nRing | 1 |
| Solubility: LogS | -4.038 | nHRing | 0 |
| Solubility: LogP | 3.909 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 24.7015 |
| nHD | 0 | BPOL | 12.0385 |
| QED | 0.551 |
| Synth | 1.847 |
| Natural Product Likeliness | -0.297 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.012 |
| Pgp-sub | 0.032 |
| HIA | 0.003 |
| CACO-2 | -4.452 |
| MDCK | 0.0000236 |
| BBB | 0.953 |
| PPB | 0.89908 |
| VDSS | 1.21 |
| FU | 0.0903035 |
| CYP1A2-inh | 0.94 |
| CYP1A2-sub | 0.937 |
| CYP2c19-inh | 0.311 |
| CYP2c19-sub | 0.83 |
| CYP2c9-inh | 0.219 |
| CYP2c9-sub | 0.839 |
| CYP2d6-inh | 0.038 |
| CYP2d6-sub | 0.915 |
| CYP3a4-inh | 0.086 |
| CYP3a4-sub | 0.421 |
| CL | 10.7 |
| T12 | 0.382 |
| hERG | 0.026 |
| Ames | 0.089 |
| ROA | 0.019 |
| SkinSen | 0.65 |
| Carcinogencity | 0.518 |
| EI | 0.995 |
| Respiratory | 0.072 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.909835 |